Telomir Pharmaceuticals Inc (TELO)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Telomir Pharmaceuticals Inc

(813) 864-2562

900 WEST PLATT STREET, SUITE 200, TAMPA

Prossima data di guadagno

Ultimi documenti SEC

TELO's Discussions on Twitter

Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie

Telomir Pharmaceuticals Inc Azioni (TELO) Dati Finanziari

Telomir Pharmaceuticals Inc (TELO)

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Telomir Pharmaceuticals Inc Borsa (TELO) Ultime notizie

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Increase in Short Interest - MarketBeat

Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 2.2% - Defense World

Telomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher - MarketBeat

What Is Going On With AST SpaceMobile Stock? - Barchart

Experience The Future Of Smart Living With Hisense At IFA 2024 - Barchart

Boeing's troubled space capsule ends mission with a landing in the New Mexico desert, leaving two astronauts in orbit - Barchart

Stakeholder In Trump's Truth Social Parent Company Wins Court Ruling Over Share Transfer - Barchart

Is RTX Corporation Stock Outperforming The S&P 500? - Barchart

US Hiring Rebounds Slightly And Unemployment Rate Dips In Sign Of Still-Slowing Job Market - Barchart

Telegram CEO Defends Himself Against French Charges In First Public Comments - Barchart

New Mexico attorney general sues company behind Snapchat alleging child sexual extortion on the site - Barchart

IGM FINANCIAL INC. ANNOUNCES AUGUST 2024 ASSETS UNDER MANAGEMENT & ADVISEMENT AND NET FLOWS - Barchart

Media AdvisoryPrime Minister's Itinerary For Friday, September 6, 2024 - Barchart

ALIMENTATION COUCHE-TARD INC. ANNOUNCES ELECTION OF DIRECTORS - Barchart

With Musk's X Banned In Brazil, Its Users Carve Out New Digital Homes - Barchart

Telomir Pharmaceuticals’ Age Reversal Drug Shows Promise in Canine Study - Vancity Buzz

Obesity Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novo Nordisk, Boehringer Ingelheim, Pfizer, BioAge Labs, Aphaia Pharma, Neothetics, NovMetaPharma, Carmot - Barchart

Applications For US Jobless Benefits Fall To 2-Month Low As Layoffs Remain At Healthy Levels - Barchart

WCAS Completes Acquisition Of EquiLend - Barchart

Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs | FinancialContent Business Page - Financial Content

Soft Tissue Sarcoma Market is expected to grow at a significant CAGR, DelveInsight | Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm - Barchart

FuelCell Energy: Fiscal Q3 Earnings Snapshot - Barchart

Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com

Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com India

Unusual Activity In Block Inc. OptionsHighlights SQ Stock's Value - Barchart

Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com Canada

Protecting Homeowners From Unnecessary Financial Stress - Barchart

US Job Openings Fall As Demand For Workers Cools - Barchart

Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Amylyx Pharma, Ionis Pharma, Annexon, Inc., UniQure Biopharma, Sangamo Therapeutics - Barchart

Litecoin May Have Bottomed - Barchart

Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com UK

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - Milton Daily Standard

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - AccessWire

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - StockTitan

Telomir Pharmaceuticals recruits ex-Synthelabo executive - Investing.com

Eaton Corporation Stock: Is ETN Outperforming The Industrials Sector? - Barchart

Is Union Pacific Corporation Stock Outperforming The Dow? - Barchart

The growth track for Telomir Pharmaceuticals Inc (TELO) has changed recently - SETE News

Quarterly Metrics: Quick and Current Ratios for Telomir Pharmaceuticals Inc (TELO) - The Dwinnex

Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart

Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga

Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Up 3.2% - MarketBeat

Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 3.2% - Defense World

Telomir-1 shows promise in aging dogs, eyes human trials - Investing.com

TELO Stock: Exploring Telomir Pharmaceuticals Inc’s Growth - The InvestChronicle

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Milton Daily Standard

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Brazosport Facts

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - AccessWire

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - StockTitan

Telomir Pharmaceuticals (NASDAQ:TELO) Stock Quotes, Forecast and News Summary - Benzinga

ABC7 Exclusive: New study reveals promising results for age reversal pill on dogs - WWSB

Telomir Pharmaceuticals Inc Azioni (TELO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a TELO